logo
  

Biogen Idec Inc. (BIIB) Has Broken Out To A New High On Strong Q4 Earnings

Biogen Idec Inc. (BIIB) reported fourth quarter non-GAAP EPS of $4.09 after the bell Thursday, up from $2.34 last year. Analysts expected EPS of $3.78. Full year 2015 non-GAAP EPS is expected to be between $16.60 and $17.00. The consensus estimate is for EPS of $16.37.

Biogen Idec gapped up sharply Friday and has spiked higher in early trade. Shares are now up 36.31 at $389.56. The stock has broken out past resistance and has set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.

Jobless claims data was the highlight in this relatively light week for U.S. economics. In Europe, focus was on the U.K. economy where the Bank of England announced its latest policy decision and the first quarter GDP data were released. Find out the signals from the central bank and whether or not the UK economy exited a recession. In the Asia-Pacific, Australia's central bank delivered its latest policy verdict and China released trade figures.

View More Videos
Follow RTT